Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
6.61
-0.53 (-7.42%)
At close: Dec 4, 2024, 4:00 PM
6.55
-0.06 (-0.91%)
After-hours: Dec 4, 2024, 7:59 PM EST

Senti Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-70.9-71.06-58.21-55.32-19.86-21.16
Depreciation & Amortization
5.875.433.923.011.991.4
Loss (Gain) From Sale of Assets
0.11-21.86----
Asset Writedown & Restructuring Costs
0.5825.96-0.020.240.01
Loss (Gain) From Sale of Investments
--1.07-0.36--0-0.29
Stock-Based Compensation
3.219.6716.392.30.270.21
Other Operating Activities
14.71-4.13-10.5514.74-5.03-
Change in Accounts Receivable
0.98-0.93-0.13-0.4-0.010.12
Change in Accounts Payable
-1.2-0.290.19-0.62-0.320.63
Change in Unearned Revenue
-0.41-0.11-1.031.830.17-
Change in Other Net Operating Assets
12.115.9914.88-0.21-1.610.71
Operating Cash Flow
-34.93-52.4-34.9-34.64-24.17-18.38
Capital Expenditures
-0.02-12.04-41.37-5.54-1.16-2
Sale of Property, Plant & Equipment
0.170.11---0.02
Investment in Securities
-42.01-40.59-12.525.73
Investing Cash Flow
0.1530.08-81.96-5.5411.363.75
Short-Term Debt Issued
----8-
Long-Term Debt Issued
--117.15---
Total Debt Issued
--117.15-8-
Long-Term Debt Repaid
--0.11--0.02--
Net Debt Issued (Repaid)
-0.02-0.11117.15-0.028-
Issuance of Common Stock
0.590.891.41.50.330.02
Other Financing Activities
2.43----0.28-0.02
Financing Cash Flow
30.78118.5568.4438.0514.01
Net Cash Flow
-31.79-21.541.728.2625.24-0.62
Free Cash Flow
-34.95-64.43-76.27-40.18-25.33-20.37
Free Cash Flow Margin
--2515.93%-1779.51%-1455.20%-4475.97%-23969.41%
Free Cash Flow Per Share
-7.69-14.52-29.21-137.96-18.28-15.00
Levered Free Cash Flow
2.95-75.14-57.23-17.92-14.27-
Unlevered Free Cash Flow
2.95-75.14-57.23-17.92-14.27-
Change in Net Working Capital
-29.4239.95-3.46-7.6-0.06-
Source: S&P Capital IQ. Standard template. Financial Sources.